Aging is inevitable and affects everyone differently. It is a natural part of life that can cause physical, mental and emotional changes. However, with the help of advancements in genetic cell therapy, the aging process can now be slowed down with the use of myoblasts and foreskin fibroblasts.
Anti-Aging Regenerative Cosmetology (AARC) is a patented technology that uses live cells to enhance the appearance and function of various bodily parts to provide health and aestheticism of human beings throughout life. This technology intervenes with and corrects the undesirable phenotypic expression of aging. The program holds promise to sustain the human subject in good health and appearance, with a good quality of life and life prolongation.
As a baby boomer approaching age 80, I am interested in the promising benefits of AARC. Myoblasts and foreskin fibroblasts have been harnessed to formulate a genetic cell therapy program which has been tested in FDA Phase III clinical trials. Myoblasts are selected for strength development and foreskin fibroblasts for tenacity and smooth-to-the-touch. Both cell types are highly mitotic and non-carcinogenic.
The earliest signs of aging are loss of energy and strength due to genetically programed degeneration of ATP-producing mitochondria. Mitochondrial degeneration diminishes energy production, body warmth, physical activity, leading to disuse atrophy and degeneration of fast-twitch muscle fibers that account for slow movement and incoordination in the elderlies.
Losses of muscle fibers and physical activity are a vicious cycle affecting not only skeletal muscles but the overlying skin also. Reductions in muscle volume coupled with constant muscle stretching and relaxation are direct causes of fine lines and wrinkles on aging skin which begins to lose elasticity, smoothness, suppleness and firmness.
Myoblasts, because of their small size, spindle shape, and resilience, grow readily on collagen and laminin within wrinkles of skin surfaces, thus enhancing the color, luster, and texture of the skin “plated” with them. Alternatively, they can be injected subcutaneously as cell filler to reduce wrinkles. Intramuscular injection of myoblasts can augment the size, shape, consistency, tone, and strength of muscle groups, improving the lines, contours, and vitality to sculpt a youthful appearance.
By improving cell genetics and organ functions, the program holds promise to sustain the human subject in good health and appearance, with a good quality of life and life prolongation. The use of myoblasts and foreskin fibroblasts is a game-changer in the fight against aging. It is an area with great promise that can facilitate the availability of safe and effective treatments for aging individuals.
In conclusion, Anti-Aging Regenerative Cosmetology is a ground-breaking technology that is revolutionizing the beauty industry. The use of genetic cell therapy with myoblasts and foreskin fibroblasts can help revitalize aging cells, providing a more youthful appearance and improving overall health. With the potential for a longer, healthier life, it is worth considering this therapy for anyone who wants to age gracefully.
Can Genetic Cell Therapy Help Slow Down Aging?
The idea of slowing down aging has fascinated humans for centuries. Aging is a complex process that involves several physiological and molecular changes in our bodies, and despite the advances in medicine and technology, we are yet to find a cure for aging. However, with the recent developments in genetic cell therapy, there is a growing interest in whether this approach can help slow down aging.
Genetic cell therapy involves the modification of genes or cells to treat or prevent diseases. The therapy has been successful in treating several genetic disorders, including cystic fibrosis and sickle cell anemia. Scientists are now exploring the possibility of using genetic cell therapy to combat aging.
One approach that scientists are investigating involves targeting senescent cells, which are cells that have stopped dividing and are no longer functional. These cells accumulate in our bodies as we age and are believed to contribute to several age-related diseases, such as cancer, cardiovascular diseases, and neurodegeneration. By targeting and eliminating these senescent cells, researchers hope to slow down the aging process and improve the quality of life for older adults.
Another approach involves the use of telomerase, an enzyme that is responsible for maintaining the length of our telomeres, which are protective caps at the end of our chromosomes. Telomeres shorten as we age, leading to cell death and tissue damage. Scientists are exploring the possibility of using genetic cell therapy to activate telomerase in aging cells, which could potentially slow down the aging process.
While genetic cell therapy shows promise in slowing down aging, there are several challenges that scientists need to overcome. One of the major challenges is ensuring the safety of the therapy, as modifying genes or cells could have unintended consequences. Additionally, the therapy is still in its early stages of development, and it could take several years before it becomes widely available.
In conclusion, genetic cell therapy has the potential to revolutionize the field of aging research and offer new hope for older adults. While the therapy is still in its infancy, the progress made so far is promising, and scientists are optimistic about the future of genetic cell therapy in aging research. However, it’s important to note that aging is a complex process, and there’s no one-size-fits-all solution to slowing it down. A combination of genetic cell therapy, lifestyle changes, and other interventions could be the key to healthy aging.
Why is loss of muscle bulk and strength the most significant deficit of aging?
Muscle loss, or sarcopenia, is a common problem that affects many people as they age. It’s not just about looking less toned or having weaker muscles; it can also have serious health consequences. In fact, loss of muscle mass and strength is considered one of the most significant deficits of aging.
So why is this such a big issue? First of all, muscle is important for maintaining balance and mobility. As we get older, weaker muscles can lead to falls and other accidents, which can cause injuries and even death. In addition, weaker muscles can make it harder to perform everyday activities, such as carrying groceries or climbing stairs. This can lead to a decrease in independence and a lower quality of life.
But there’s more to it than just mobility issues. Muscle is also important for overall health. It helps to regulate blood sugar levels, and it plays a key role in metabolism. In fact, people with less muscle mass are more likely to develop conditions like type 2 diabetes, obesity, and cardiovascular disease.
So, what can be done to prevent or slow down muscle loss as we age? Regular exercise, especially resistance training, can be helpful. A healthy diet with enough protein can also help to maintain muscle mass. And while there’s no magic pill to reverse the effects of aging, researchers are exploring new treatments such as genetic cell therapy to help slow down or even reverse muscle loss.
In summary, loss of muscle mass and strength is a significant deficit of aging that can have serious health consequences. By staying active and eating a healthy diet, we can help to maintain our muscles and overall health as we age. And who knows, maybe new treatments like genetic cell therapy will offer even more hope for healthy aging in the future.
What are the earliest signs of aging?
Firstly, changes in your skin can be one of the earliest signs of aging. As we age, our skin becomes thinner, drier, and less elastic, leading to wrinkles, age spots, and sagging skin. You may also notice that your skin bruises more easily and takes longer to heal.
Secondly, changes in your vision can also be an early sign of aging. You may find that you need more light to see clearly, or that it’s harder to see things up close. You may also experience dry eyes or have trouble differentiating colors.
Thirdly, you may start to notice changes in your memory and thinking abilities. It may become more difficult to remember names, dates, or events, and you may find it harder to multitask or learn new things.
Fourthly, changes in your energy levels can also be an early sign of aging. You may find that you tire more easily and need more rest than before.
While these changes may seem concerning, it’s important to remember that they are a natural part of the aging process. However, there are things we can do to slow down the process and maintain our health and vitality as we age. Regular exercise, a healthy diet, and staying socially active are just a few examples of things we can do to promote healthy aging.
So, if you’re starting to notice some of these early signs of aging, don’t worry! With the right lifestyle habits and mindset, you can continue to live a happy and fulfilling life for many years to come.
What are Myoblasts and Foreskin Fibroblasts, and How Can They Improve Cell Regeneration?
First of all, Myoblasts are a type of stem cell found in muscles that have the ability to differentiate into muscle cells. They are essential for muscle growth and repair, and research has shown that they can also help with tissue regeneration in other parts of the body.
On the other hand, Foreskin Fibroblasts are a type of skin cell that has been shown to have regenerative properties. They are particularly useful in wound healing, and have been studied for their potential use in treating burns and other skin injuries.
So, how can these cells be used to improve cell regeneration? Well, researchers have been exploring the potential of using Myoblasts and Foreskin Fibroblasts in cell therapy, a type of treatment that involves transplanting healthy cells into damaged or diseased tissue to promote healing and regeneration.
In the case of Myoblasts, studies have shown that they can be used to improve the regeneration of damaged tissues such as the heart, liver, and nervous system. Similarly, Foreskin Fibroblasts have been studied for their potential use in skin regeneration, and have shown promising results in the treatment of burns and other skin injuries.
Overall, Myoblasts and Foreskin Fibroblasts are both important types of cells that have the potential to improve cell regeneration and promote healing in a variety of tissues throughout the body. As research continues in this field, it’s exciting to think about the potential for these cells to revolutionize the way we approach the treatment of injuries and diseases.
Thank you for reading my article on the promising benefits of Anti-Aging Regenerative Cosmetology (AARC) using myoblasts and foreskin fibroblasts. I hope you found it informative and engaging. If you have any questions or thoughts on the topic, please leave a comment below. Your feedback and input are highly appreciated and valuable to me.
If you enjoyed this article, please consider subscribing to my blog for more interesting and informative content on the latest advancements in health and beauty. Also, if you found this article helpful, it would mean a lot if you could share it on social media. By sharing this information, you can help spread awareness of the potential benefits of genetic cell therapy and AARC.
Thank you for taking the time to read this article, and I hope it has inspired you to consider the potential benefits of Anti-Aging Regenerative Cosmetology with myoblasts and foreskin fibroblasts. Let’s embrace aging gracefully with the latest advancements in genetic cell therapy.
References:
[1] Campisi, J., Kapahi, P., Lithgow, G.J., et al. (2019) From Discoveries in Ageing Research to Therapeutics for Healthy Ageing. Nature, 571, 182-192.
https://doi.org/10.1038/s41586-019-1365-2
[2] Law, P.K., Bertorini, T., Goodwin, T.G., et al. (1990) Dystrophin Production Induced by Myoblast Transfer Therapy in Duchenne Muscular Dystrophy. The Lancet, 336, 114-115.
https://doi.org/10.1016/0140-6736(90)91628-N
[3] Law, P.K., Law, D.M., Ye, L., et al. (2019) Myoblasts Provide Safe and Effective Treatments for Hereditary Muscular Dystrophies, Cardiomyopathies, Type 2 Diabetes, Solid Tumors and Aging. In: Haider, K.H. and Aziz, S., Eds., Stem Cells—From Hype to Real Hope, Walter de Gruyter GmbH, Berlin, 71-97.
https://doi.org/10.1515/9783110587043-004
[4] Law, P.K., Li, W., Song, Q., et al. (2022) Chapter 22. Myoblast Therapies Constitute a Safe and Efficacious Platform Technology of Regenerative Medicine for the Human Health Industry. In: Haider, K.H. and Aziz, S., Eds., Stem Cells Latest Advances, Springer Nature GmbH, Berlin, 1-66.
https://doi.org/10.1007/978-981-16-6016-0_34-1
[5] Marks, P. and Gottlieb, S. (2018) Balancing Safety and Innovation for Cell-Based Regenerative Medicine. The New England Journal of Medicine, 378, 954-959.
https://doi.org/10.1056/NEJMsr1715626
[6] Law, P.K. (1994) Myoblast Transfer: Gene Therapy for Muscular Dystrophy. RG Landes Co., Austin.
[7] Law, P.K. (1995) Methods for Human Myoblast Culture and Transplantation. In: Recordi, C., Ed., Methods in Cell Transplantation, RG Landes Co., Austin, Sec. H5, 707-730.
[8] Law, P.K. and Law, D.M. (2011) Human Myoblast Genome Therapies and Devices in Regenerative Medicine. Recent Patents on Regenerative Medicine, 1, 88-117.
https://doi.org/10.2174/2210297311101010088
[9] Mimeault, M. and Batra, S.K. (2009) Recent Insights into the Molecular Mechanisms Involved in Aging and the Malignant Transformation of Adult Stem/Progenitor Cells and Their Therapeutic Implications. Ageing Research Reviews, 8, 94-112.
https://doi.org/10.1016/j.arr.2008.12.001
[10] Law, P.K., Saito, A. and Fleischer, S. (1983) Ultrastructural Changes in Muscle and Motor Endplate of the Dystrophic Mouse. Experimental Neurology, 80, 361-382.
https://doi.org/10.1016/0014-4886(83)90289-3
[11] Sullivan, D. (2021) “Whole-Body Mitochondrial Transfusion” Start-Up Lands Funding. Longevity Technology, January 28, 2021.
[12] Law, P.K. (2016) Disease Prevention and Alleviation by Human Myoblast Transplantation. Open Journal of Regenerative Medicine, 5, 25-43.
https://doi.org/10.4236/ojrm.2016.52003
[13] Law, P.K. (2017) Crime against Humanity. Open Journal of Regenerative Medicine, 6, 35-645.
https://doi.org/10.4236/ojrm.2017.64004
[14] Law, P.K., Law, D.M., Lu, P., et al. (2004) The World’s First Myoblast Study of Type II Diabetic Patients. Business Briefing: North American Pharmacotherapy No. 2.
[15] Peng, Y., Xuan, M., Leung, V.Y.L. and Cheng, B. (2015) Stem Cells and Aberrant Signaling of Molecular Systems in Skin Aging. Ageing Research Reviews, 19, 8-21.
https://doi.org/10.1016/j.arr.2014.10.006
[16] Godic, A. (2019) The Role of Stem Cells in Anti-Aging Medicine. Clinics in Dermatology, 37, 320-325.
https://doi.org/10.1016/j.clindermatol.2019.04.011
[17] Di Donna, S., Mamchaoui, K., Cooper, R.N., et al. (2003) Telomerase Can Extend the Proliferative Capacity of Human Myoblasts but Does Not Lead to Their Immortalization. Molecular Cancer Research, 1, 643-653.
[18] Xiong, M., Zhang, Q., Hu, W., et al. (2021) The Novel Mechanisms and Applications of Exosomes in Dermatology and Cutaneous Medical Aesthetics. Pharmacological Research, 166, Article ID: 105490.
https://doi.org/10.1016/j.phrs.2021.105490
[19] Giri, S., Machens, H.-G. and Bader, A. (2019) Therapeutic Potential of Endogenous Stem Cells and Cellular Factors for Scar-Free Skin Regeneration. Drug Discovery Today, 24, 69-84.
https://doi.org/10.1016/j.drudis.2018.10.014
[20] Law, P.K., Sim, E.K.W., Haider, Kh.H., et al. (2004) Myoblast Genome Therapy and the Regenerative Heart. In: Kipshidze, N.N. and Serruys, P.W., Eds., Handbook of Cardiovascular Cell Transplantation, Martin Dunitz, London, 241-258.
[21] Ye, L., Lee, K.O., Su, L.P., et al. (2009) Skeletal Myoblast Transplantation for Attenuation of Hyperglycaemia, Hyperinsulinaemia and Glucose Intolerance in a Mouse Model of Type 2 Diabetes Mellitus. Diabetologia, 52, 1925-1934.
https://doi.org/10.1007/s00125-009-1421-9
[22] Ma, J.H., Su, L.P., Zhu, J., et al. (2013) Skeletal Myoblast Transplantation on Gene Expression Profiles of Insulin Signaling Pathway and Mitochondrial Biogenesis and Function in Skeletal Muscle. Diabetes Research and Clinical Practice, 102, 43-52.
https://doi.org/10.1016/j.diabres.2013.08.006
[23] Law, P.K. (2002) Concomitant Angiogenesis/Myogenesis in the Regenerative Heart. Business Briefing: Future Drug Discovery, Genomics: 64-67, October 2002.
[24] Law, P.K., Haider, K., Fang, G., et al. (2004) Human VEGF165-Myoblasts Produce Concomitant Angiogenesis/Myogenesis in the Regenerative Heart. Molecular and Cellular Biochemistry, 263, 173-178.
https://doi.org/10.1023/B:MCBI.0000041859.60354.f5
[25] Ye, L., Haider, H.Kh., Jiang, S., et al. (2003) High Efficiency Transduction of Human VEGF165 into Human Skeletal Myoblasts: In Vitro Studies. Experimental & Molecular Medicine, 35, 412-420.
https://doi.org/10.1038/emm.2003.54
[26] Ye, L., Haider, H.Kh., Jiang, S., et al. (2005) In Vitro Functional Assessment of Human Skeletal Myoblasts after Transduction with Adenoviral Bi-Cistronic Vector Carrying Human VEGF165 and Angiopoietin-1. The Journal of Heart and Lung Transplantation, 24, 1393-1402.
https://doi.org/10.1016/j.healun.2004.06.004
[27] Ye, L., Haider, H.Kh., Tan, R.S., et al. (2007) Transplantation of Nanoparticle Transfected Skeletal Myoblasts Overexpressing Vascular Endothelial Growth Factor-165 for Cardiac Repair. Circulation, 116, 113-120.
https://doi.org/10.1161/CIRCULATIONAHA.106.680124
[28] Ye, L., Haider, H.Kh., Tan, R., et al. (2008) Angiomyogenesis Using Liposome Based Vascular Endothelial Growth Factor-165 Transfection with Skeletal Myoblast for Cardiac Repair. Biomaterials, 29, 2125-2137.
https://doi.org/10.1016/j.biomaterials.2008.01.014
[29] Haider, H.K.H., Ye, L., Jiang, S., et al. (2004) Angiomyogenesis for Cardiac Repair Using Human Myoblasts as Carriers of Human Vascular Endothelial Growth Factor. Journal of Molecular Medicine, 82, 539-549.
https://doi.org/10.1007/s00109-004-0546-z
[30] Law, P.K., Law, D.L., Lu, P., et al. (2006) Human Myoblast Genome Therapy. Journal of Geriatric Cardiology, 3, 135-151.
[31] Rigotti, G., Charles-de-Sá, L., Gontijo-de-Amorim, N.F., et al. (2016) Expanded Stem Cells, Stromal-Vascular Fraction, and Platelet-Rich Plasma Enriched Fat: Comparing Results of Different Facial Rejuvenation Approaches in a Clinical Trial. Aesthetic Surgery Journal, 36, 261-270.
https://doi.org/10.1093/asj/sjv231
[32] Katagiri, T., Yamaguchi, A., Komaki, M., et al. (1994) Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblast into the Osteoblast Lineage. Journal of Cell Biology, 127, 1755-1766.
https://doi.org/10.1083/jcb.127.6.1755
[33] Cheng, W., Law, P., Kwan, H. and Cheng, R. (2014) Stimulation Therapies and the Relevance of Fractal Dynamics to the Treatment of Diseases. Open Journal of Regenerative Medicine, 3, 73-94.
https://doi.org/10.4236/ojrm.2014.34009
[34] Chen, B., Wang, B., Zhang, W.J., Zhou, G. and Cao, Y. (2012) In Vivo Tendon Engineering with Skeletal Muscle Derived Cells in a Mouse Model. Biomaterials, 33, 6086-6097.
https://doi.org/10.1016/j.biomaterials.2012.05.022
[35] Crowley, J.S., Liu, A. and Dobke, M. (2021) Regenerative and Stem Cell-Based Techniques for Facial Rejuvenation. Experimental Biology and Medicine, 246, 1829-1837.
https://doi.org/10.1177/15353702211020701
[36] Law, P. and Ren, J. (2023) Genetic Cell Therapy in Anti-Aging Regenerative Cosmetology. Open Journal of Regenerative Medicine, 12, 1-20. doi: 10.4236/ojrm.2023.121001.
